pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,172 catalysts · 5,901 phase readout · 2,265 8k filing · 408 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,901
  • 8k filing2,265
  • earnings408
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05523245: Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: . Conditions: Rectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07625072: Mental Rehearsal in Emergency Cricothyroidotomy Training

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06060977: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04027777: Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07299877: Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block

Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks

full page →ctgov ↗
›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

full page →ctgov ↗
›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07556601: Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility

full page →ctgov ↗
›RECRUITINGphase readoutNCT04799301: Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07541001: PRL3-Zumab in Patients With Advanced Solid Tumors

Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07606001: Yellow Potatoes and Carotenoids

Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

full page →ctgov ↗
›RECRUITINGphase readoutNCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

full page →ctgov ↗
›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07474688: Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure

Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01969227: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06545461: Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT06037161: Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07506486: Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study)

Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07336186: The Effect of Virtual Reality-Based Relaxation on Breast Milk Volume and Breastfeeding Self-Efficacy in Mothers of Preterm Infants

Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy

full page →ctgov ↗
›WITHDRAWNphase readoutNCT05089786: Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)

Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology

full page →ctgov ↗
›RECRUITINGphase readoutNCT07634770: Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07619469: Motion Sickness Severity and Sensorimotor Performance

Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness

full page →ctgov ↗
›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

full page →ctgov ↗
›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

full page →ctgov ↗
›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

full page →ctgov ↗
›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

full page →ctgov ↗
›RECRUITINGphase readoutNCT05558566: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence

full page →ctgov ↗
›COMPLETEDphase readoutNCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07570329: Human Milk Oligosaccharides, Gut Bifidobacterium, Vitamin D, and Infant Immunity

Sponsor: Hasanuddin University. Phase: . Conditions: Healhty

full page →ctgov ↗
›COMPLETEDphase readoutNCT05203731: Level of Physical Activity and Fear Learning

Sponsor: NYU Langone Health. Phase: NA. Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06156202: Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT04857502: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma

full page →ctgov ↗
← prev
page 110 of 164
next →